Nature's Sunshine reported an 8% increase in net sales, reaching a record $110.5 million, but experienced a GAAP net loss of $2.7 million, or $(0.15) per diluted share. The company faced headwinds from COVID-19, global supply chain issues, inflation, and the war in Ukraine, which negatively impacted productivity and resulted in inventory-related impairment charges.
Net sales increased by 8% to $110.5 million, a new quarterly record.
GAAP net loss was $(2.7) million, or $(0.15) per diluted share, compared to a net income of $4.2 million, or $0.20 per diluted share in the same quarter last year.
Adjusted EBITDA decreased to $8.2 million from $11.6 million in the prior year.
The company faced $4.2 million in inventory-related impairment charges due to external factors.
Nature's Sunshine anticipates overcoming near-term challenges through continued investment, a strong balance sheet, global growth strategies, and belief in the long-term potential of the business.
Visualization of income flow from segment revenue to net income